Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (ICAR)
This study has been terminated.
Sponsor:
Rennes University Hospital
Collaborator:
Innate Pharma
Information provided by (Responsible Party):
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT00562666
First received: November 21, 2007
Last updated: June 21, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | January 2009 |
| Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |